We aim to bring novel antibiotics and medicines for high medical needs to patients. Polyphor's goal is to be the leader in the development of novel antibiotics and other efficacious therapies agains...
We aim to bring novel antibiotics and medicines for high medical needs to patients. Polyphor's goal is to be the leader in the development of novel antibiotics and other efficacious therapies against specialty diseases with high medical needs. Polyphor was founded in 1996 and is a clinical stage, privately held Swiss specialty pharma company, based in Allschwil near Basel. It focuses on the development of macrocycle drugs that address antibiotic resistance and severe respiratory diseases.